Rahul D. Ballal, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 38,500 shares at $53.32 ($2.1M) on 2024-11-07, disclosed to the SEC on 2024-11-12.
Scheduled sale ($2.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.32 | 8,132 | $434K | 20.2% |
| 2 | $53.32 | 8,132 | $434K | 20.2% |
| 3 | $54.41 | 1,868 | $102K | 4.7% |
| 4 | $54.41 | 1,868 | $102K | 4.7% |
| 5 | $57.24 | 3,571 | $204K | 9.5% |
| 6 | $57.24 | 3,571 |
| $204K |
| 9.5% |
| 7 | $58.57 | 4,929 | $289K | 13.5% |
| 8 | $58.57 | 4,929 | $289K | 13.5% |
| 9 | $59.21 | 1,500 | $89K | 4.1% |
| Total | $55.73 avg | 38,500 | $2.1M | 100% |
| Filing → |
| ELVN | SELL | 2024-04-08 | $133K | — | Filing → |
| ELVN | SELL | 2024-04-03 | $124K | — | Filing → |
| ELVN | SELL | 2024-03-22 | $509K | — | Filing → |